The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADTALEM GLOBAL ED INC | COM | 00737L103 | 102,127 | 2,974 | SH | SOLE | 2,974 | 0 | 0 | ||
VANGUARD INDEX FDS | S&P 500 ETF SHS | 922908363 | 33,867,194 | 82,834 | SH | SOLE | 82,834 | 0 | 0 | ||
VANGUARD BD INDEX FDS TOTAL BND MRKT | TOTAL BND MRKT | 921937835 | 96,462,683 | 1,327,042 | SH | SOLE | 1,327,042 | 0 | 0 | ||
VANGUARD INTL EQUITY INDEX F | TT WRLD ST ETF | 922042742 | 7,877,976 | 81,233 | SH | SOLE | 81,233 | 0 | 0 | ||
ISHARE CORE MSCI EAFE ETF | CORE MSCI EAFE | 46432F842 | 80,676,000 | 1,195,200 | SH | SOLE | 1,195,200 | 0 | 0 | ||
PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | 124,751 | 48,731 | SH | SOLE | 48,731 | 0 | 0 | ||
ADTALEM GLOBAL ED INC | COM | 00737L103 | 303,051 | 8,825 | SH | SOLE | 8,825 | 0 | 0 |